After ten years of quiet research, Pulsar Fusion has unveiled a nuclear fusion-powered rocket called the Sunbird. This spacecraft isn’t just another science fiction concept—it’s being designed to fly ...

The latest news, announced Sunday, is that Airbus will design and build the lander that will carry the ExoMars down to the surface of Mars. The mission is scheduled to launch no earlier than 2028 on a ...

Isar Aerospace, based in Germany, is the first in a crop of new European rocket companies to attempt an orbital launch. If ...

Demand for solid rocket motors is booming in part because missile makers are aggressively ramping up output of all sorts of ...

Lunar Executor is a tool for executing custom scripts within Roblox, providing users with the ability to exploit and modify game features.

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise. At this point, being fast is beside the point for the ...

Game engines are crucial for creating visually stunning games, with some being better for entry-level developers. Various game engines cater to different needs, from beginner-friendly to ...

The Lockheed-Martin F-22 Raptor is powered by two Pratt & Whitney F119-PW-100 turbofan engines specifically designed to support its fifth-generation stealth fighter capabilities. These engines are ...

GameSpot may get a commission from retail offers. Developer Psyonix has announced a futuristic theme for Rocket League Season 18, with this new season kicking off on March 14. The season brings a ...

SUVs are getting larger while their V8 and V6 engines have been replaced by smaller motors. Smaller turbocharged engines benefit from improved fuel economy and better mid-range torque. But ...

Rocket Cos. is pushing deeper into the property market with a deal to buy Redfin Corp. that values the real estate listing site at $1.75 billion. The Detroit-based financial technology group will ...

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that the Kyowa Kirin-partnered rocatinlimab improves outcomes in atopic ...